One-year intranasal application of growth hormone releasing peptide-2 improves body weight and hypoglycemia in a severely emaciated anorexia nervosa patient

BACKGROUND: In Japan, growth hormone releasing peptide-2 (GHRP-2) is clinically used as a diagnostic agent for growth hormone secretion deficiency, but the therapeutic application of GHRP-2 has not been studied in anorexia nervosa. GHRP-2 reportedly exhibits agonistic action for ghrelin receptor and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cachexia Sarcopenia Muscle
Main Authors: Haruta, Izumi, Fuku, Yuki, Kinoshita, Kazuhisa, Yoneda, Koichi, Morinaga, Akinori, Amitani, Marie, Amitani, Haruka, Asakawa, Akihiro, Sugawara, Hideki, Takeda, Yasuo, Bowers, Cyril Y, Inui, Akio
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2015
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4575555/
https://ncbi.nlm.nih.gov/pubmed/26401470
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcsm.12028
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados